Higher-risk MDS and AML: How new guidelines are changing diagnosis, classification and management

Описание к видео Higher-risk MDS and AML: How new guidelines are changing diagnosis, classification and management

The 2022 updates of international guidelines affect diagnosis, classification and management of HR-MDS and AML.

Get up-to-date on their impact on clinical practice with expert perspectives.

Watch now: https://touchhaematology.com/educatio...

With Prof. Andrew Wei, Prof. Agnieszka Wierzbowska and Prof. Gert Ossenkoppele.

--------
This activity is supported by an independent medical education grant from Novartis and is provided by touchIME.

Комментарии

Информация по комментариям в разработке